Condition: Oropharyngeal Cancer · Carcinoma · Sponsor: Zachary Zumsteg
This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visible disease at the primary site and in the lymph nodes.
This description comes directly from the study's public registry record.
Clinical Trial Navigator · 3104232133 · GroupCancerTrialInformation@cshs.org
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Cancer at Beverly Hills (THO) | Beverly Hills, California, United States | Recruiting |
| Cedars Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| CS Cancer at Valley Oncology Medical Group | Tarzana, California, United States | Recruiting |
| CS Cancer at the Hunt Cancer Center | Torrance, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06445114